NO970800D0 - Spiroazabicykliske forbindelser som er nyttige i terapi - Google Patents

Spiroazabicykliske forbindelser som er nyttige i terapi

Info

Publication number: NO970800D0
Authority: NO; Norway
Prior art keywords: spiroazabicyclic; therapy; compounds useful; compounds; useful
Prior art date: 1994-08-24

Application number

NO970800A

Other languages

English (en)

Other versions

NO307707B1 (no

NO970800L (no

Inventor

Michael Balestra

John Charles Gordon

Ronald Conrad Griffith

Robert John Murray

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-24

Filing date

1997-02-21

Publication date

1997-02-21

1994-08-24 Priority claimed from GB9417084A external-priority patent/GB9417084D0/en

1995-03-08 Priority claimed from GBGB9504627.2A external-priority patent/GB9504627D0/en

1997-02-21 Application filed by Astra Ab filed Critical Astra Ab

1997-02-21 Publication of NO970800L publication Critical patent/NO970800L/no

1997-02-21 Publication of NO970800D0 publication Critical patent/NO970800D0/no

2000-05-15 Publication of NO307707B1 publication Critical patent/NO307707B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO970800A 1994-08-24 1997-02-21 Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav NO307707B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9417084A GB9417084D0 (en)	1994-08-24	1994-08-24	Compounds useful in therapy
GBGB9504627.2A GB9504627D0 (en)	1995-03-08	1995-03-08	Compounds for use in therapy
PCT/SE1995/000937 WO1996006098A1 (en)	1994-08-24	1995-08-22	Spiro-azabicyclic compounds useful in therapy

Publications (3)

Publication Number	Publication Date
NO970800L NO970800L (no)	1997-02-21
NO970800D0 true NO970800D0 (no)	1997-02-21
NO307707B1 NO307707B1 (no)	2000-05-15

Family

ID=26305509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO970800A NO307707B1 (no)	1994-08-24	1997-02-21	Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav

Country Status (33)

Country	Link
US (2)	US5902814A (no)
EP (1)	EP0777671B1 (no)
JP (1)	JP3708962B2 (no)
KR (1)	KR100366331B1 (no)
CN (2)	CN1056846C (no)
AR (1)	AR031828A2 (no)
AT (1)	ATE192157T1 (no)
AU (1)	AU690735B2 (no)
BR (1)	BR9508751A (no)
CA (1)	CA2196995C (no)
CZ (1)	CZ289512B6 (no)
DE (1)	DE69516524T2 (no)
DK (1)	DK0777671T3 (no)
EE (1)	EE03399B1 (no)
EG (1)	EG24222A (no)
ES (1)	ES2145922T3 (no)
FI (1)	FI112868B (no)
GR (1)	GR3033878T3 (no)
HU (1)	HUT77352A (no)
IL (1)	IL115039A (no)
IS (1)	IS1852B (no)
MX (1)	MX9701292A (no)
NO (1)	NO307707B1 (no)
NZ (1)	NZ292289A (no)
PL (1)	PL183933B1 (no)
PT (1)	PT777671E (no)
RU (1)	RU2148058C1 (no)
SA (1)	SA95160370B1 (no)
SK (1)	SK282366B6 (no)
TR (1)	TR199501053A2 (no)
TW (1)	TW397837B (no)
UA (1)	UA54375C2 (no)
WO (1)	WO1996006098A1 (no)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5977144A (en) *	1992-08-31	1999-11-02	University Of Florida	Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
AR013184A1 (es)	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
US6277870B1 (en)	1998-05-04	2001-08-21	Astra Ab	Use
SE9900100D0 (sv)	1999-01-15	1999-01-15	Astra Ab	New compounds
JP4564135B2 (ja) *	1999-07-26	2010-10-20	住友化学株式会社	高純度フェノチアジン化合物とその製造方法、およびその中間体の製造方法、並びにその中間体の原料の水和物と新規結晶
WO2001066546A1 (en) *	2000-03-09	2001-09-13	Mitsubishi Pharma Corporation	Spiro compounds, process for preparing the same and use thereof as drugs
US8914114B2 (en)	2000-05-23	2014-12-16	The Feinstein Institute For Medical Research	Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
AU2001286938A1 (en) *	2000-08-28	2002-03-13	Colorado State University Research Foundation	Compounds containing oxazolidinone moiety and uses thereof
US6569865B2 (en)	2001-06-01	2003-05-27	Astrazeneca Ab	Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
US20040259909A1 (en) *	2001-10-16	2004-12-23	Mccarthy Dennis	Treatment of fibromyalgia syndrome
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
US20040048795A1 (en) *	2002-02-26	2004-03-11	North Shore-Long Island Jewish Research Institute	Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
SE0202598D0 (sv) *	2002-09-02	2002-09-02	Astrazeneca Ab	Alpha-7 Nicotinic receptor agonists and statins in combination
US7238715B2 (en) *	2002-12-06	2007-07-03	The Feinstein Institute For Medical Research	Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
DE60317564T2 (de) *	2002-12-06	2008-10-23	The Feinstein Institute For Medical Research	Hemmung von entzündungen unter verwendung von alpha-7-rezeptor verbindenden cholinergen agonisten
AU2004255920B2 (en) *	2003-07-08	2008-05-15	Astrazeneca Ab	Spiro [1-azabicyclo [2.2.2] octan-3,5'-oxazolidin]-2'-one derivatives with affinity to the alpha7 nicotinic acetylcholine receptor
US10912712B2 (en)	2004-03-25	2021-02-09	The Feinstein Institutes For Medical Research	Treatment of bleeding by non-invasive stimulation
WO2005092308A2 (en) *	2004-03-25	2005-10-06	The Feinstein Institute For Medical Research	Neural tourniquet
US20080113983A1 (en) *	2004-12-15	2008-05-15	Astrazeneca Ab	Nicotinic Acetylcholine Receptor Ligands
CN101124012B (zh)	2004-12-27	2012-09-05	范因斯坦医学研究院	通过电刺激迷走神经治疗炎症性疾病的装置
US11207518B2 (en)	2004-12-27	2021-12-28	The Feinstein Institutes For Medical Research	Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
JP2008525524A (ja) *	2004-12-28	2008-07-17	アストラゼネカ・アクチエボラーグ	アリールスルホンアミドモジュレーター
EP2258358A3 (en)	2005-08-26	2011-09-07	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
EP2275096A3 (en)	2005-08-26	2011-07-13	Braincells, Inc.	Neurogenesis via modulation of the muscarinic receptors
RU2326787C2 (ru) *	2005-11-09	2008-06-20	Сергей Федорович Бокарев	Способ управления крылом, помещенным в текучую среду, при его взаимодействии с этой средой и устройство для его осуществления
US8316104B2 (en)	2005-11-15	2012-11-20	California Institute Of Technology	Method and apparatus for collaborative system
EP2083921A2 (en)	2006-09-04	2009-08-05	Neurosearch A/S	Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
BRPI0716604A2 (pt)	2006-09-08	2013-04-09	Braincells Inc	combinaÇÕes contendo um derivado de 4-acilaminopiridina
US8391970B2 (en)	2007-08-27	2013-03-05	The Feinstein Institute For Medical Research	Devices and methods for inhibiting granulocyte activation by neural stimulation
DE102008015999B4 (de)	2008-03-27	2011-04-21	Novar Gmbh	Übertragungsweg - Prüfverfahren für eine Gefahrenmeldeanlage
WO2009146030A1 (en) *	2008-03-31	2009-12-03	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation of t-cell activity
US9662490B2 (en)	2008-03-31	2017-05-30	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US7863291B2 (en) *	2008-04-23	2011-01-04	Bristol-Myers Squibb Company	Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
US8309577B2 (en)	2008-04-23	2012-11-13	Bristol-Myers Squibb Company	Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
WO2009154563A1 (en)	2008-06-20	2009-12-23	Astrazeneca Ab	Dibenzothiazepine derivatives and use thereof
ES2452484T3 (es)	2008-11-18	2014-04-01	Setpoint Medical Corporation	Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
HUE037938T2 (hu)	2008-11-19	2018-09-28	Forum Pharmaceuticals Inc	Skizofrénia negatív tüneteinek kezelése (R)-7-klór-N-(kinuklidin-3-il)benzo[b]tiofén-2-karboxamiddal és ennek gyógyszerészetileg elfogadható sójával
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
US8996116B2 (en)	2009-10-30	2015-03-31	Setpoint Medical Corporation	Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US8788034B2 (en)	2011-05-09	2014-07-22	Setpoint Medical Corporation	Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9211410B2 (en)	2009-05-01	2015-12-15	Setpoint Medical Corporation	Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
JP5808319B2 (ja) *	2009-05-11	2015-11-10	フォルムファーマシューティカルズ、インコーポレイテッド	アセチルコリンエステラーゼ阻害剤と組み合わせた特定のα７ニコチン酸受容体を用いた認知障害の治療
EP2440284B1 (en)	2009-06-09	2018-09-12	Setpoint Medical Corporation	Nerve cuff with pocket for leadless stimulator
CN102686595A (zh)	2009-10-28	2012-09-19	百时美施贵宝公司	作为α-7 烟碱乙酰胆碱受体配体的氮杂二环化合物
US8278320B2 (en)	2009-10-28	2012-10-02	Bristol-Myers Squibb Company	Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
WO2014169145A1 (en)	2013-04-10	2014-10-16	Setpoint Medical Corporation	Closed-loop vagus nerve stimulation
US9833621B2 (en)	2011-09-23	2017-12-05	Setpoint Medical Corporation	Modulation of sirtuins by vagus nerve stimulation
EP2515996B1 (en)	2009-12-23	2019-09-18	Setpoint Medical Corporation	Neural stimulation devices and systems for treatment of chronic inflammation
WO2011137313A1 (en)	2010-04-30	2011-11-03	Bristol-Myers Squibb Company	Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs
ES2570657T3 (es)	2010-05-17	2016-05-19	Forum Pharmaceuticals Inc	Una forma cristalina de hidrocloruro de (R)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidrato
US12172017B2 (en)	2011-05-09	2024-12-24	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
US9572983B2 (en)	2012-03-26	2017-02-21	Setpoint Medical Corporation	Devices and methods for modulation of bone erosion
WO2013169646A1 (en)	2012-05-08	2013-11-14	Envivo Pharmaceuticals, Inc.	Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
ES2694299T3 (es)	2013-02-07	2018-12-19	Heptares Therapeutics Limited	Carboxilatos de piperidin-1-ilo y azepin-1-ilo como agonistas del receptor muscarínico M4
EA029430B1 (ru)	2013-06-21	2018-03-30	Такеда Фармасьютикл Компани Лимитед	Производные 1-сульфонилпиперидина в качестве модуляторов рецепторов прокинетицина
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
US11311725B2 (en)	2014-10-24	2022-04-26	Setpoint Medical Corporation	Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en)	2015-02-03	2022-08-09	Setpoint Medical Corporation	Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en)	2016-01-13	2020-03-24	Setpoint Medical Corporation	Systems and methods for establishing a nerve block
US10695569B2 (en)	2016-01-20	2020-06-30	Setpoint Medical Corporation	Control of vagal stimulation
US11471681B2 (en)	2016-01-20	2022-10-18	Setpoint Medical Corporation	Batteryless implantable microstimulators
EP3405255B1 (en)	2016-01-20	2025-12-31	Setpoint Medical Corporation	IMPLANTABLE MICROSTIMULATORS AND INDUCTION CHARGING SYSTEMS
US10583304B2 (en)	2016-01-25	2020-03-10	Setpoint Medical Corporation	Implantable neurostimulator having power control and thermal regulation and methods of use
US10661112B2 (en)	2016-07-25	2020-05-26	Tonal Systems, Inc.	Digital strength training
US11745039B2 (en)	2016-07-25	2023-09-05	Tonal Systems, Inc.	Assisted racking of digital resistance
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
US11173307B2 (en)	2017-08-14	2021-11-16	Setpoint Medical Corporation	Vagus nerve stimulation pre-screening test
US10589163B2 (en)	2017-10-02	2020-03-17	Tonal Systems, Inc.	Exercise machine safety enhancements
US10617903B2 (en)	2017-10-02	2020-04-14	Tonal Systems, Inc.	Exercise machine differential
US10486015B2 (en)	2017-10-02	2019-11-26	Tonal Systems, Inc.	Exercise machine enhancements
US10335626B2 (en)	2017-10-02	2019-07-02	Tonal Systems, Inc.	Exercise machine with pancake motor
US11660443B2 (en)	2018-04-20	2023-05-30	The Feinstein Institutes For Medical Research	Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation
US11260229B2 (en)	2018-09-25	2022-03-01	The Feinstein Institutes For Medical Research	Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
CN113939334A (zh)	2019-04-12	2022-01-14	赛博恩特医疗器械公司	迷走神经刺激来处理神经退行性障碍
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤
IL298193B2 (en)	2020-05-21	2024-01-01	Feinstein Institutes For Medical Research	Systems and methods for vagus nerve stimulation
US11285355B1 (en)	2020-06-08	2022-03-29	Tonal Systems, Inc.	Exercise machine enhancements
US11878204B2 (en)	2021-04-27	2024-01-23	Tonal Systems, Inc.	First repetition detection
US11998804B2 (en)	2021-04-27	2024-06-04	Tonal Systems, Inc.	Repetition phase detection
WO2022245878A1 (en)	2021-05-17	2022-11-24	Setpoint Medical Corporation	Neurostimulation parameter authentication and expiration system for neurostimulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH601304A5 (no) *	1974-02-12	1978-07-14	Buskine Sa
US4028351A (en) *	1971-09-07	1977-06-07	Buskine S.A.	Method for the preparation of derivatives of spiro (4,5)-decane and derivatives thus obtained
SU495310A1 (ru) *	1974-03-05	1975-12-15	Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе	Хинуклидил-3-диарал(гетерил) карбинолы, про вл ющие антигистаминную, антисеротониновую и антиаллергическую активность и способ их получени
GB8808433D0 (en) *	1988-04-11	1988-05-11	Merck Sharp & Dohme	Therapeutic agents
GB8816299D0 (en) *	1988-07-08	1988-08-10	Merck Sharp & Dohme	Therapeutic agents
IL97726A (en) *	1990-04-10	1994-12-29	Israel Inst Biolog Res	Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds
US5534520A (en) *	1990-04-10	1996-07-09	Fisher; Abraham	Spiro compounds containing five-membered rings
US5073560A (en) *	1990-07-20	1991-12-17	Fisons Corporation	Spiro-isoxazolidine derivatives as cholinergic agents
US5137895A (en) *	1991-04-29	1992-08-11	A. H. Robins Company, Incorporated	3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols

1995
- 1995-08-22 DK DK95930755T patent/DK0777671T3/da active
- 1995-08-22 US US08/525,575 patent/US5902814A/en not_active Expired - Fee Related
- 1995-08-22 ES ES95930755T patent/ES2145922T3/es not_active Expired - Lifetime
- 1995-08-22 SK SK216-97A patent/SK282366B6/sk not_active IP Right Cessation
- 1995-08-22 WO PCT/SE1995/000937 patent/WO1996006098A1/en not_active Ceased
- 1995-08-22 CZ CZ1997392A patent/CZ289512B6/cs not_active IP Right Cessation
- 1995-08-22 PL PL95318760A patent/PL183933B1/pl not_active IP Right Cessation
- 1995-08-22 EP EP95930755A patent/EP0777671B1/en not_active Expired - Lifetime
- 1995-08-22 RU RU97104165A patent/RU2148058C1/ru not_active IP Right Cessation
- 1995-08-22 PT PT95930755T patent/PT777671E/pt unknown
- 1995-08-22 HU HU9701965A patent/HUT77352A/hu unknown
- 1995-08-22 DE DE69516524T patent/DE69516524T2/de not_active Expired - Fee Related
- 1995-08-22 BR BR9508751A patent/BR9508751A/pt not_active IP Right Cessation
- 1995-08-22 NZ NZ292289A patent/NZ292289A/en not_active IP Right Cessation
- 1995-08-22 JP JP50799596A patent/JP3708962B2/ja not_active Expired - Fee Related
- 1995-08-22 CN CN95195518A patent/CN1056846C/zh not_active Expired - Fee Related
- 1995-08-22 EE EE9700039A patent/EE03399B1/xx not_active IP Right Cessation
- 1995-08-22 UA UA97031329A patent/UA54375C2/uk unknown
- 1995-08-22 CA CA002196995A patent/CA2196995C/en not_active Expired - Fee Related
- 1995-08-22 KR KR1019970701159A patent/KR100366331B1/ko not_active Expired - Fee Related
- 1995-08-22 AT AT95930755T patent/ATE192157T1/de not_active IP Right Cessation
- 1995-08-22 MX MX9701292A patent/MX9701292A/es unknown
- 1995-08-22 AU AU34018/95A patent/AU690735B2/en not_active Ceased
- 1995-08-23 EG EG70395A patent/EG24222A/xx active
- 1995-08-23 IL IL11503995A patent/IL115039A/xx not_active IP Right Cessation
- 1995-08-24 TW TW084108836A patent/TW397837B/zh not_active IP Right Cessation
- 1995-08-24 TR TR95/01053A patent/TR199501053A2/xx unknown
- 1995-11-08 SA SA95160370A patent/SA95160370B1/ar unknown
1997
- 1997-02-03 IS IS4424A patent/IS1852B/is unknown
- 1997-02-21 NO NO970800A patent/NO307707B1/no not_active IP Right Cessation
- 1997-02-24 FI FI970762A patent/FI112868B/fi active
1998
- 1998-11-09 US US09/188,099 patent/US6051581A/en not_active Expired - Fee Related
1999
- 1999-11-08 CN CN99123574A patent/CN1099419C/zh not_active Expired - Fee Related
2000
- 2000-04-10 AR ARP000101632A patent/AR031828A2/es unknown
- 2000-07-04 GR GR20000401563T patent/GR3033878T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
SK21697A3 (en)	1997-09-10
FI112868B (fi)	2004-01-30
NO307707B1 (no)	2000-05-15
JPH10504561A (ja)	1998-05-06
IL115039A (en)	2001-08-26
TR199501053A2 (tr)	1996-06-21
BR9508751A (pt)	1997-08-12
HUT77352A (hu)	1998-03-30
RU2148058C1 (ru)	2000-04-27
PL183933B1 (pl)	2002-08-30
ES2145922T3 (es)	2000-07-16
FI970762A0 (fi)	1997-02-24
WO1996006098A1 (en)	1996-02-29
CZ289512B6 (cs)	2002-02-13
CN1159808A (zh)	1997-09-17
GR3033878T3 (en)	2000-11-30
EP0777671B1 (en)	2000-04-26
IL115039A0 (en)	1995-12-08
HK1010370A1 (en)	1999-06-17
SK282366B6 (sk)	2002-01-07
AU690735B2 (en)	1998-04-30
FI970762L (fi)	1997-02-24
CZ39297A3 (en)	1997-12-17
CA2196995A1 (en)	1996-02-29
EP0777671A1 (en)	1997-06-11
DK0777671T3 (da)	2000-07-24
CA2196995C (en)	2008-05-13
IS4424A (is)	1997-02-03
US5902814A (en)	1999-05-11
EE03399B1 (et)	2001-04-16
CN1056846C (zh)	2000-09-27
NO970800L (no)	1997-02-21
AU3401895A (en)	1996-03-14
US6051581A (en)	2000-04-18
DE69516524D1 (de)	2000-05-31
EG24222A (en)	2008-11-10
MX9701292A (es)	1997-05-31
ATE192157T1 (de)	2000-05-15
PT777671E (pt)	2000-08-31
DE69516524T2 (de)	2001-01-18
TW397837B (en)	2000-07-11
CN1099419C (zh)	2003-01-22
AR031828A2 (es)	2003-10-08
UA54375C2 (uk)	2003-03-17
PL318760A1 (en)	1997-07-07
SA95160370B1 (ar)	2006-06-04
CN1284505A (zh)	2001-02-21
EE9700039A (et)	1997-08-15
NZ292289A (en)	1998-05-27
KR100366331B1 (ko)	2003-04-10
JP3708962B2 (ja)	2005-10-19
IS1852B (is)	2003-02-21

Publication	Publication Date	Title
NO970800L (no)	1997-02-21	Spiroazabicykliske forbindelser som er nyttige i terapi
DE69524193D1 (de)	2002-01-10	Massagegerät
DK0769017T3 (da)	2000-09-11	Terapeutiske forbindelser
FI942119A0 (fi)	1994-05-06	Anordning i en gasblandare
DE69504051D1 (de)	1998-09-17	Synergistisches entlackungsmittel
DE69514764D1 (de)	2000-03-02	Massagegerät
FI961339L (fi)	1996-03-22	Triaryylieteenijohdannaiset käytettäväksi hoidossa
FI1516U1 (fi)	1994-09-20	Foerpackning foer i stapel anordnade smaoark
FI962961A0 (fi)	1996-07-24	Telebetalningssystem i realtid
MD281F1 (ro)	1995-09-30	Masajor magnetodinamic
KR960013388U (ko)	1996-05-17	지압기
KR950032251U (ko)	1995-12-14	사우나용 찜질방 구조
KR960009986U (ko)	1996-04-12	마사지기
FI944788A0 (fi)	1994-10-12	Skidstav som foeljer roerelse
KR960004028U (ko)	1996-02-14	쑥뜸 구
FI1750U1 (fi)	1995-02-09	Stol
FI944668A0 (fi)	1994-10-05	Hopfaellbar stol
FI1418U1 (fi)	1994-07-20	Sopkaerlsutrustning foer montering i skaop
FI1410U1 (fi)	1994-06-27	Bocklyftare foer materialbehandling i hamnar
FI944267A0 (fi)	1994-09-15	Regn- och vindtak foer foeraren i en hydraulisk virkeskran
FI941445A0 (fi)	1994-03-29	Pressdel i en pappersmaskin
FI950920A0 (fi)	1995-02-28	Pressdel i en pappersmaskin
FI942901A0 (fi)	1994-06-17	Luftfjaedring i en fyrtaktsfoerbraenningsmotors vevhus
FI940694A0 (fi)	1994-02-15	Anordning i taendsystem
FI1727U1 (fi)	1995-01-26	Ansiktsskydd i samband med haortvaettning

Legal Events

Date	Code	Title	Description
2010-03-22	MM1K	Lapsed by not paying the annual fees